Research Paper Volume 13, Issue 12 pp 16513—16526

Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer

Correlation between prognosis and clinicopathological characteristics. (A–C) Correlation analysis between scores and survival of colon cancer patients (p=0.932, 0.432, and 0.544 for ImmuneScore, StromalScore, and ESTIMATEScore, respectively; log-rank test). (D–F) Correlation analysis of ImmuneScore, StromalScore, and ESTIMATEScore with stage (p=0.011, 0.514, and 0.332, separately; Kruskal–Wallis rank sum test). (G–I) Correlation analysis of three scores with T classification (p=0.975, 0.318, and 0.82, respectively; Kruskal–Wallis rank sum test). (J–L) Correlation analysis of ImmuneScore, StromalScore, and ESTIMATEScore with M classification (p=0.001, 0.695, and 0.072, separately; Wilcoxon rank sum test). (M–O) Correlation analysis of Immune, Stromal, and ESTIMATE Scores with N classification (p=0.13, 0.15, and 0.571, respectively; Kruskal–Wallis rank sum test).

Figure 1. Correlation between prognosis and clinicopathological characteristics. (AC) Correlation analysis between scores and survival of colon cancer patients (p=0.932, 0.432, and 0.544 for ImmuneScore, StromalScore, and ESTIMATEScore, respectively; log-rank test). (DF) Correlation analysis of ImmuneScore, StromalScore, and ESTIMATEScore with stage (p=0.011, 0.514, and 0.332, separately; Kruskal–Wallis rank sum test). (GI) Correlation analysis of three scores with T classification (p=0.975, 0.318, and 0.82, respectively; Kruskal–Wallis rank sum test). (JL) Correlation analysis of ImmuneScore, StromalScore, and ESTIMATEScore with M classification (p=0.001, 0.695, and 0.072, separately; Wilcoxon rank sum test). (MO) Correlation analysis of Immune, Stromal, and ESTIMATE Scores with N classification (p=0.13, 0.15, and 0.571, respectively; Kruskal–Wallis rank sum test).